ARWR logo

ARWR Free cash flow

annual FCF:

-$604.32M-$273.69M(-82.78%)
September 30, 2024

Summary

  • As of today (May 29, 2025), ARWR annual free cash flow is -$604.32 million, with the most recent change of -$273.69 million (-82.78%) on September 30, 2024.
  • During the last 3 years, ARWR annual FCF has fallen by -$752.07 million (-509.03%).
  • ARWR annual FCF is now -475.27% below its all-time high of $161.03 million, reached on September 30, 2019.

Performance

ARWR Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRcash flow metrics

quarterly FCF:

$454.76M+$608.54M(+395.70%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ARWR quarterly free cash flow is $454.76 million, with the most recent change of +$608.54 million (+395.70%) on March 31, 2025.
  • Over the past year, ARWR quarterly FCF has increased by +$581.21 million (+459.63%).
  • ARWR quarterly FCF is now at all-time high.

Performance

ARWR quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRcash flow metrics

TTM FCF:

$9.60M+$581.21M(+101.68%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ARWR TTM free cash flow is $9.60 million, with the most recent change of +$581.21 million (+101.68%) on March 31, 2025.
  • Over the past year, ARWR TTM FCF has increased by +$479.76 million (+102.04%).
  • ARWR TTM FCF is now -94.25% below its all-time high of $166.83 million, reached on June 30, 2021.

Performance

ARWR TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

ARWR Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-82.8%+459.6%+102.0%
3 y3 years-509.0%+684.4%+112.8%
5 y5 years-475.3%+1557.8%+121.0%

ARWR Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-509.0%at lowat high+343.8%at high+101.6%
5 y5-year-475.3%at lowat high+343.8%-94.3%+101.6%
alltimeall time-475.3%at lowat high+343.8%-94.3%+101.6%

ARWR Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$454.76M(-395.7%)
$9.60M(-101.7%)
Dec 2024
-
-$153.79M(-4.8%)
-$571.61M(-5.4%)
Sep 2024
-$604.32M(+82.8%)
-$161.50M(+24.4%)
-$604.32M(+13.5%)
Jun 2024
-
-$129.87M(+2.7%)
-$532.65M(+13.3%)
Mar 2024
-
-$126.45M(-32.2%)
-$470.16M(+16.8%)
Dec 2023
-
-$186.50M(+107.6%)
-$402.70M(+21.8%)
Sep 2023
-$330.63M(+75.0%)
-$89.83M(+33.3%)
-$330.63M(-3.4%)
Jun 2023
-
-$67.38M(+14.2%)
-$342.24M(-3.1%)
Mar 2023
-
-$58.98M(-48.5%)
-$353.21M(+49.5%)
Dec 2022
-
-$114.43M(+12.8%)
-$236.25M(+25.1%)
Sep 2022
-$188.91M(-227.9%)
-$101.45M(+29.5%)
-$188.91M(+57.8%)
Jun 2022
-
-$78.35M(-235.1%)
-$119.69M(+59.8%)
Mar 2022
-
$57.98M(-186.4%)
-$74.88M(-160.5%)
Dec 2021
-
-$67.09M(+108.2%)
$123.85M(-16.2%)
Sep 2021
$147.75M(-237.1%)
-$32.23M(-3.9%)
$147.75M(-11.4%)
Jun 2021
-
-$33.54M(-113.1%)
$166.83M(+1.2%)
Mar 2021
-
$256.71M(-694.3%)
$164.81M(-233.9%)
Dec 2020
-
-$43.19M(+228.6%)
-$123.10M(+14.2%)
Sep 2020
-$107.75M(-166.9%)
-$13.14M(-63.0%)
-$107.75M(+21.6%)
Jun 2020
-
-$35.56M(+14.0%)
-$88.63M(+93.7%)
Mar 2020
-
-$31.19M(+12.0%)
-$45.76M(+33.2%)
Dec 2019
-
-$27.85M(-565.8%)
-$34.36M(-121.3%)
Sep 2019
$161.03M(-431.0%)
$5.98M(-18.1%)
$161.03M(+6.2%)
Jun 2019
-
$7.30M(-136.9%)
$151.66M(+16.9%)
Mar 2019
-
-$19.80M(-111.8%)
$129.75M(-3.0%)
Dec 2018
-
$167.55M(-5042.7%)
$133.73M(-374.9%)
Sep 2018
-$48.64M(+52.7%)
-$3.39M(-76.8%)
-$48.64M(-10.9%)
Jun 2018
-
-$14.61M(-7.7%)
-$54.57M(+5.9%)
Mar 2018
-
-$15.82M(+6.7%)
-$51.53M(+0.3%)
Dec 2017
-
-$14.83M(+59.2%)
-$51.39M(+61.3%)
Sep 2017
-$31.86M(-53.3%)
-$9.31M(-19.5%)
-$31.86M(-10.1%)
Jun 2017
-
-$11.57M(-26.2%)
-$35.44M(-17.3%)
Mar 2017
-
-$15.68M(-433.4%)
-$42.87M(+2.0%)
Dec 2016
-
$4.70M(-136.5%)
-$42.03M(-38.5%)
Sep 2016
-$68.29M(+0.9%)
-$12.89M(-32.1%)
-$68.29M(+0.1%)
Jun 2016
-
-$19.00M(+28.0%)
-$68.25M(+8.9%)
Mar 2016
-
-$14.84M(-31.1%)
-$62.65M(-2.8%)
Dec 2015
-
-$21.55M(+67.7%)
-$64.48M(-4.7%)
Sep 2015
-$67.68M(+82.3%)
-$12.86M(-4.1%)
-$67.68M(+2.2%)
Jun 2015
-
-$13.40M(-19.6%)
-$66.21M(+4.7%)
Mar 2015
-
-$16.67M(-32.7%)
-$63.23M(+15.5%)
Dec 2014
-
-$24.75M(+117.4%)
-$54.75M(+47.4%)
Sep 2014
-$37.13M(+92.1%)
-$11.39M(+9.3%)
-$37.13M(+18.8%)
Jun 2014
-
-$10.42M(+27.2%)
-$31.25M(+18.7%)
Mar 2014
-
-$8.19M(+14.7%)
-$26.32M(+16.4%)
Dec 2013
-
-$7.14M(+29.8%)
-$22.62M(+17.0%)
Sep 2013
-$19.33M(+22.2%)
-$5.50M(+0.1%)
-$19.33M(+4.5%)
Jun 2013
-
-$5.50M(+22.4%)
-$18.51M(+8.8%)
Mar 2013
-
-$4.49M(+16.7%)
-$17.02M(+0.7%)
Dec 2012
-
-$3.85M(-17.7%)
-$16.89M(+6.8%)
Sep 2012
-$15.82M
-$4.67M(+16.7%)
-$15.82M(+23.5%)
Jun 2012
-
-$4.00M(-8.3%)
-$12.81M(+30.3%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$4.37M(+57.3%)
-$9.83M(+45.6%)
Dec 2011
-
-$2.78M(+66.8%)
-$6.75M(+25.0%)
Sep 2011
-$5.40M(-29.9%)
-$1.66M(+61.8%)
-$5.40M(-13.6%)
Jun 2011
-
-$1.03M(-20.1%)
-$6.25M(-10.7%)
Mar 2011
-
-$1.29M(-9.7%)
-$7.00M(-6.5%)
Dec 2010
-
-$1.42M(-43.3%)
-$7.49M(-2.7%)
Sep 2010
-$7.70M(-49.7%)
-$2.51M(+41.3%)
-$7.70M(+1.3%)
Jun 2010
-
-$1.78M(+0.2%)
-$7.60M(+3.9%)
Mar 2010
-
-$1.77M(+8.6%)
-$7.32M(-28.4%)
Dec 2009
-
-$1.63M(-32.4%)
-$10.22M(-33.2%)
Sep 2009
-$15.32M(-45.8%)
-$2.42M(+61.5%)
-$15.32M(-28.6%)
Jun 2009
-
-$1.50M(-68.0%)
-$21.46M(-22.7%)
Mar 2009
-
-$4.68M(-30.4%)
-$27.77M(-4.2%)
Dec 2008
-
-$6.73M(-21.4%)
-$29.00M(+2.6%)
Sep 2008
-$28.27M(+14.8%)
-$8.56M(+9.6%)
-$28.27M(+7.1%)
Jun 2008
-
-$7.81M(+32.3%)
-$26.40M(+7.1%)
Mar 2008
-
-$5.90M(-1.6%)
-$24.64M(-3.1%)
Dec 2007
-
-$6.00M(-10.3%)
-$25.42M(+3.2%)
Sep 2007
-$24.62M(+56.6%)
-$6.69M(+10.6%)
-$24.62M(+12.4%)
Jun 2007
-
-$6.05M(-9.5%)
-$21.90M(+5.9%)
Mar 2007
-
-$6.68M(+28.3%)
-$20.68M(+17.2%)
Dec 2006
-
-$5.21M(+31.1%)
-$17.65M(+12.2%)
Sep 2006
-$15.73M(+60.9%)
-$3.97M(-17.6%)
-$15.73M(+9.9%)
Jun 2006
-
-$4.82M(+32.0%)
-$14.30M(+13.0%)
Mar 2006
-
-$3.65M(+11.1%)
-$12.66M(+17.9%)
Dec 2005
-
-$3.29M(+28.9%)
-$10.73M(+9.8%)
Sep 2005
-$9.77M(+227.9%)
-$2.55M(-19.7%)
-$9.77M(+16.8%)
Jun 2005
-
-$3.17M(+83.8%)
-$8.37M(+34.4%)
Mar 2005
-
-$1.73M(-25.7%)
-$6.22M(+24.9%)
Dec 2004
-
-$2.32M(+103.2%)
-$4.98M(+67.3%)
Sep 2004
-$2.98M(+1765.9%)
-$1.14M(+11.2%)
-$2.98M(+54.2%)
Jun 2004
-
-$1.03M(+111.3%)
-$1.93M(+112.1%)
Mar 2004
-
-$486.90K(+52.1%)
-$910.90K(+97.2%)
Dec 2003
-
-$320.20K(+232.5%)
-$461.90K(+193.1%)
Sep 2003
-$159.70K(+48.6%)
-$96.30K(+1184.0%)
-$157.60K(+109.0%)
Jun 2003
-
-$7500.00(-80.2%)
-$75.40K(-35.5%)
Mar 2003
-
-$37.90K(+138.4%)
-$116.90K(+21.0%)
Dec 2002
-
-$15.90K(+12.8%)
-$96.60K(-10.2%)
Sep 2002
-$107.50K(+31.4%)
-$14.10K(-71.2%)
-$107.60K(-0.6%)
Jun 2002
-
-$49.00K(+178.4%)
-$108.20K(+45.0%)
Mar 2002
-
-$17.60K(-34.6%)
-$74.60K(-17.0%)
Dec 2001
-
-$26.90K(+83.0%)
-$89.90K(+9.8%)
Sep 2001
-$81.80K(+1.2%)
-$14.70K(-4.5%)
-$81.90K(-7.2%)
Jun 2001
-
-$15.40K(-53.2%)
-$88.30K(-34.3%)
Mar 2001
-
-$32.90K(+74.1%)
-$134.30K(+33.9%)
Dec 2000
-
-$18.90K(-10.4%)
-$100.30K(+24.0%)
Sep 2000
-$80.80K(+129.5%)
-$21.10K(-65.6%)
-$80.90K(+35.3%)
Jun 2000
-
-$61.40K(-5681.8%)
-$59.80K(-3837.5%)
Mar 2000
-
$1100.00(+120.0%)
$1600.00(+220.0%)
Dec 1999
-
$500.00
$500.00
Sep 1999
-$35.20K(<-9900.0%)
-
-
Sep 1998
$100.00(-97.8%)
-
-
Sep 1997
$4600.00
-
-

FAQ

  • What is Arrowhead Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals annual FCF year-on-year change?
  • What is Arrowhead Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals quarterly FCF year-on-year change?
  • What is Arrowhead Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals TTM FCF year-on-year change?

What is Arrowhead Pharmaceuticals annual free cash flow?

The current annual FCF of ARWR is -$604.32M

What is the all time high annual FCF for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high annual free cash flow is $161.03M

What is Arrowhead Pharmaceuticals annual FCF year-on-year change?

Over the past year, ARWR annual free cash flow has changed by -$273.69M (-82.78%)

What is Arrowhead Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of ARWR is $454.76M

What is the all time high quarterly FCF for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high quarterly free cash flow is $454.76M

What is Arrowhead Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, ARWR quarterly free cash flow has changed by +$581.21M (+459.63%)

What is Arrowhead Pharmaceuticals TTM free cash flow?

The current TTM FCF of ARWR is $9.60M

What is the all time high TTM FCF for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high TTM free cash flow is $166.83M

What is Arrowhead Pharmaceuticals TTM FCF year-on-year change?

Over the past year, ARWR TTM free cash flow has changed by +$479.76M (+102.04%)
On this page